+69.9%
AZN vs THC
+237.8%
-167.9%
-27.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.6% | -0.2% | -0.5% | -0.6% |
| 7D | -5.5% | -8.0% | +2.5% | -4.4% |
| 30D | +3.5% | -2.2% | +5.7% | +3.8% |
| 3M | +6.0% | -3.5% | +9.4% | +6.4% |
| 6M | -7.0% | +40.4% | -47.4% | -11.4% |
| YTD | -4.2% | +32.4% | -36.6% | -8.3% |
| 1Y | -0.7% | +41.0% | -41.7% | -5.8% |
| 3Y | +44.1% | +305.2% | -261.1% | +15.9% |
| All | +69.9% | +237.8% | -167.9% | +38.2% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling